Search for: "Bayer v. Bayer"
Results 561 - 580
of 1,122
Sorted by Relevance
|
Sort by Date
5 Jun 2011, 1:12 pm
Bayer Corp. [read post]
19 Jul 2012, 9:18 am
Related Posts: Armstrong v. [read post]
30 Sep 2009, 5:41 am
., Inc. et al. v. [read post]
2 May 2009, 9:21 am
" Abad v. [read post]
19 May 2011, 9:24 pm
Bayer AG v. [read post]
13 Sep 2012, 2:03 pm
(5) Examine the impact of the judgment in Natco v Bayer and its significance for developing countries in the field of compulsory licensing.The committee also organizes the Belles-Lettres J.E. [read post]
6 May 2017, 10:11 am
”Bayer Schering Pharma AG v. [read post]
9 Mar 2011, 3:00 am
Bayer AG (FDA Law Blog) (Patent Docs) Melatonin – EWCA refers SPC questions to the ECJ: Neurim Pharmaceuticals (1991) Ltd v Comptroller General of Patents (The SPC Blog) (The SPC Blog) (EPLAW) (IPKat) Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
15 Dec 2009, 7:34 am
” Bayer v. [read post]
21 Jul 2012, 3:53 pm
Tygart | Texas Federal Court Will Hear Lance Armstrong Case on August 10, Disputing, July 18, 2012 Armstrong v. [read post]
17 Jan 2022, 1:08 am
Whilst the fact of the cases differ, the PTAB and CAFC reasoning in Teva vs Corcept is markedly different, for example, to the reasoning of the UK High Court in Bayer v Teva [2021] EWHC 2690 (Pat) (IPKat) and Actavis v ICOS (IPKat), in which inventions arising from multi-step drug development programs were found obvious-to-try in view of a known treatment effect for a particular drug, regardless of whether there was an unpredictable technical effect. [read post]
28 Sep 2011, 1:56 am
Highlights this week included: US: CAFC: Patent exhaustion does not apply to genetically engineered seed: Monsanto Co. v. [read post]
8 Dec 2010, 2:20 am
(IP tango) Bulgaria: Supreme Administrative Court: additional term to respond or amend preclusive: Vitreo v. [read post]
10 Sep 2010, 1:21 am
Bayer AG, 05-2851-cv(L) Supreme Court, Nassau County Court Rejects Service on 11-Year Old in Foreclosure Action Citibank Trust Bank FSB v. [read post]
26 Feb 2017, 3:31 am
Katfriend Gill Grassie (Brodies LLP) discusses the matter of Tartan Army Ltd v Sett GmbH and Others [2017] CSOH 22. [read post]
16 Jul 2015, 8:21 am
Bayer Corp., 2009 WL 5865687, at *8 (E.D. [read post]
8 Nov 2010, 7:51 am
Bayer Corp. (09-1205) — right of absent class members to bring a new class-action lawsuit in state court; due process violation 1 p.m. session: Stern v. [read post]
1 May 2009, 9:00 am
Products Alimta (Pemetrexed) – US: Eli Lilly files patent infringement suit over Barr’s ANDA to manufacture generic Alimta (Patent Docs) Arthrotech (Diclofenac/Misoprostol) – US: Pfizer files patent infringement suit against Teva over generic Arthrotech ANDA (Patent Docs) Enablex (Darifenacin hydrobromide) – US: Watson files ANDA to market generic Enablex prior to expiration of Novartis’ patent (GenericsWeb) Flanax (Naproxen) –… [read post]
22 Jun 2011, 4:09 am
Highlights this week included: US Supreme Court to revisit patentable subject matter eligibility of medical diagnostic methods: Mayo v Prometheus (Patently-O) (Patent Baristas) (PharmaPatents) (IPBiz) (Patent Law Practice Center) Baytril (Enrofloxacin) – US: In a rare move, District Court extends 30-month stay on FDA ANADA approval: Bayer Healthcare v Norbrook (FDA Law Blog) Europe seizure of generic drugs: Lilly settles with Indian generics (Generic… [read post]
24 Feb 2010, 2:11 am
Co. v Doll (Filewrapper) US: District Court Massachusetts denies bid for bench trial in RNAi patent suit: Max-Planck-Gesellschaft v Whitehead Institute for Biomedical Research (Patent Docs) US: Court of Appeal for the Ninth Circuit: Federal jurisdiction found in Neuralstem v Reneuron (Patent Docs) US: District Court New Jersey: Disqualification of counsel in patent case requires ‘factual analysis’, not ‘automatic disqualification rule’: Wyeth et al… [read post]
